Literature DB >> 1322926

Microheterogeneity of S-glycoprotein of mouse hepatitis virus temperature-sensitive mutants.

E L Oleszak1, K Knisley, L S Rodkey, J L Leibowitz.   

Abstract

Mouse hepatitis virus (MHV) strain JHM (MHV-JHM) is a neurotropic coronavirus that causes acute fatal encephalomyelitis in 75-99% of infected mice. The surviving animals may subsequently develop demyelinating disease. We compared the S peplomer protein of the wild type (wt) and five temperature-sensitive (ts) mutants of MHV-JHM. In contrast with the wt, none of these five cause fatal disease (mortality less than 10%). Three of these ts mutants did not induce any demyelinating disease, a fourth caused demyelinating disease in 5% of the animals and a fifth, designated ts8, exhibited strong demyelinating properties and caused demyelination in 99% of the animals. SDS-PAGE analysis revealed no differences in the molecular weight of S peplomer protein of wt or ts MHV-JHM mutants. However, isoelectric focusing of the S protein of these five ts mutants and the wt MHV-JHM, followed by transfer to nitrocellulose sheets and immunoblotting with anti-S specific antibody revealed significant differences in the microheterogeneity of the S protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322926      PMCID: PMC7119594          DOI: 10.1016/0166-0934(92)90173-b

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  40 in total

1.  The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: definition of critical epitopes by variant analysis.

Authors:  H Wege; J Winter; R Meyermann
Journal:  J Gen Virol       Date:  1988-01       Impact factor: 3.891

2.  Disc immunoelectrofocusing: application to rabbit serum proteins.

Authors:  N Catsimpoolas
Journal:  Immunochemistry       Date:  1969-05

3.  Specific characterization of isoelectrofocused immunoglobulins in polyacrylamide gel by reaction with 125 I-labeled protein antigens or antibodies.

Authors:  K Keck; A L Grossberg; D Pressmann
Journal:  Eur J Immunol       Date:  1973-02       Impact factor: 5.532

4.  Contribution of oligosaccharide sulfation to the charge heterogeneity of a viral glycoprotein.

Authors:  C H Hsu; D W Kingsbury
Journal:  J Biol Chem       Date:  1982-08-10       Impact factor: 5.157

5.  Isoelectric focusing of human antibodies directed against a high molecular weight antigen.

Authors:  L Nye; I M Roitt
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

6.  Nucleotide sequence of the gene encoding the surface projection glycoprotein of coronavirus MHV-JHM.

Authors:  I Schmidt; M Skinner; S Siddell
Journal:  J Gen Virol       Date:  1987-01       Impact factor: 3.891

7.  Target and effector cell fusion accounts for B lymphocyte-mediated lysis of mouse hepatitis virus-infected cells.

Authors:  M Wysocka; R Korngold; J Yewdell; J Bennink
Journal:  J Gen Virol       Date:  1989-06       Impact factor: 3.891

8.  Selection of a single antibody-forming cell clone and its propagation in syngeneic mice.

Authors:  B A Askonas; A R Williamson; B E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  1970-11       Impact factor: 11.205

9.  Comparison of six different murine coronavirus JHM variants by monoclonal antibodies against the E2 glycoprotein.

Authors:  F Taguchi; J O Fleming
Journal:  Virology       Date:  1989-03       Impact factor: 3.616

10.  Tunicamycin resistant glycosylation of coronavirus glycoprotein: demonstration of a novel type of viral glycoprotein.

Authors:  K V Holmes; E W Doller; L S Sturman
Journal:  Virology       Date:  1981-12       Impact factor: 3.616

View more
  2 in total

1.  Exploiting lectin affinity chromatography in clinical diagnosis.

Authors:  P R Satish; A Surolia
Journal:  J Biochem Biophys Methods       Date:  2001-10-30

2.  Characterization of bovine coronavirus isolates/from eight different states in the USA.

Authors:  S Kapil; K L Richardson; T R Maag; S M Goyal
Journal:  Vet Microbiol       Date:  1999-06-30       Impact factor: 3.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.